Suppr超能文献

[地昔帕明诱导的β-肾上腺素能受体下调:去甲肾上腺素能和5-羟色胺能神经元活动以及α2-肾上腺素能受体介导机制的影响]

[Desipramine-induced down regulation of beta-adrenergic receptors: effects of noradrenergic and serotonergic neuronal activities and of alpha 2-adrenergic receptor mediated mechanisms].

作者信息

Matsubara S

出版信息

Hokkaido Igaku Zasshi. 1987 Mar;62(2):301-10.

PMID:3038720
Abstract

The mechanisms of antidepressant (desipramine)-induced down regulation of beta-adrenergic receptors were investigated. The number of beta-adrenergic receptors in rat cerebral cortex was increased by the destruction of norepinephrine (NE) neurons with 6-hydroxydopamine or DSP-4 pretreatments. Desipramine (DMI)-induced down regulation of beta-receptors was completely prevented by these procedures, whereas the destruction of serotonin (5-HT) neurons neither changed the receptor number nor prevented the DMI-induced down regulation. The number of beta-adrenergic receptors showed a decrease within 3 days by treatment of DMI plus (+) mianserin or yohimbine which promotes NE and 5-HT release from nerve endings through presynaptic alpha 2-adrenergic antagonism. Another alpha 2-adrenergic antagonist (-)mianserin, which promotes only 5-HT release, also accelerated the down regulation induced by DMI, but this acceleration was not prevented by the destruction of 5-HT neurons. Combination of DMI with 5-HT releasing agent methiothepin (5-HT autoreceptor antagonist) did not accelerate beta-receptor down regulation. These results suggest that 1) NE availability in the synaptic cleft plays a significant role in the regulation of beta-receptor number, but 2) postsynaptic alpha 2-adrenergic mechanisms also seem to contribute to the regulation, whereas 3) 5-HT neurons have no significant effect on the process.

摘要

对抑郁症药物(地昔帕明)诱导的β-肾上腺素能受体下调机制进行了研究。用6-羟基多巴胺或DSP-4预处理破坏去甲肾上腺素(NE)神经元,可增加大鼠大脑皮质中β-肾上腺素能受体的数量。这些处理完全阻止了地昔帕明(DMI)诱导的β受体下调,而破坏5-羟色胺(5-HT)神经元既不改变受体数量,也不阻止DMI诱导的下调。通过DMI加(+)米安色林或育亨宾治疗,β-肾上腺素能受体数量在3天内减少,(+)米安色林或育亨宾通过突触前α2-肾上腺素能拮抗作用促进NE和5-HT从神经末梢释放。另一种仅促进5-HT释放的α2-肾上腺素能拮抗剂(-)米安色林也加速了DMI诱导的下调,但这种加速不受5-HT神经元破坏的影响。DMI与5-HT释放剂甲硫噻平(5-HT自受体拮抗剂)联合使用不会加速β受体下调。这些结果表明:1)突触间隙中的NE可用性在β受体数量调节中起重要作用;2)突触后α2-肾上腺素能机制似乎也参与调节;3)5-HT神经元对该过程无显著影响。

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验